SCHEMBL6993159

SCHEMBL6993159

CC(=O)Nc1ccc(-c2[nH]nc3c2CCc2ccccc2-3)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.52
RAB9A P51151 4/20 0.51
GSR P00390 1/20 0.49
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.46
IDO1 P14902 1/20 0.45
CHEK1 O14757 2/20 0.44
DYRK1B Q9Y463 2/20 0.42
DYRK1A Q13627 1/20 0.42
CYP1A2 P05177 1/20 0.42
ADRA2A P08913 1/20 0.42
MAOA P21397 1/20 0.42
SLC6A2 P23975 1/20 0.42
HTR2C P28335 1/20 0.42
SLC6A4 P31645 1/20 0.42
HTR2B P41595 1/20 0.42
MAPT P10636 1/20 0.42
CCNE2 O96020 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000769 0.80 CHEK1 (0.64) NPC1RAB9AIDO1CHEK1CYP1A2
SCHEMBL11839656 0.80 NPC1 (0.51) NPC1RAB9AGSRKMT2ACHEK1
SCHEMBL11861088 0.79 KDR (0.56) NPC1RAB9AGSRCHEK1DYRK1A
Hydrochloric Acid SCHEMBL7089690 0.79 CHEK1 (0.62) NPC1RAB9AIDO1CHEK1CYP1A2
SCHEMBL79522 0.78 NPC1 (0.83) NPC1RAB9AGSRKMT2APOLB
SCHEMBL6969848 0.77 NPC1 (0.48) NPC1RAB9AGSRCHEK1DYRK1A
SCHEMBL6963849 0.77 NPC1 (0.50) NPC1RAB9AGSRKMT2APOLB
SCHEMBL6962802 0.77 CDK4 (0.51) NPC1RAB9AGSRKMT2APOLB
SCHEMBL8063320 0.76 NPC1 (0.65) NPC1RAB9AGSRCHEK1DYRK1A
Methane SCHEMBL8064257 0.75 NPC1 (0.64) NPC1RAB9AGSRCHEK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed